Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Operating Expenses (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Operating Expenses for 3 consecutive years, with $54.7 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 8.72% to $54.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $220.0 million through Dec 2025, down 28.4% year-over-year, with the annual reading at $220.0 million for FY2025, 28.4% down from the prior year.
  • Operating Expenses hit $54.7 million in Q4 2025 for Guardian Pharmacy Services, down from $58.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $165.5 million in Q3 2024 to a low of $39.1 million in Q4 2023.
  • Historically, Operating Expenses has averaged $62.5 million across 3 years, with a median of $53.0 million in 2025.
  • Biggest five-year swings in Operating Expenses: skyrocketed 182.78% in 2024 and later tumbled 64.73% in 2025.
  • Year by year, Operating Expenses stood at $39.1 million in 2023, then rose by 28.92% to $50.3 million in 2024, then rose by 8.72% to $54.7 million in 2025.
  • Business Quant data shows Operating Expenses for GRDN at $54.7 million in Q4 2025, $58.4 million in Q3 2025, and $55.6 million in Q2 2025.